Table 1.
Percentages of T cell subpopulations expressing VLA-4 and HLA-DR in Control, versus Asymptomatic and Cardiac chagasic groups.
| Markers (%) | Control (n = 20) | Asymptomatic (n = 20) | Cardiac (n = 26) |
|---|---|---|---|
| CD3+ | 70.51 ± 1.986 | 62.22 ± 2.158** | 62.64 ± 2.342* |
| CD3+HLADR+ | 7.437 ± 1.002 | 13.7 ± 1.797** | 26.82 ± 2.704**** |
| CD3+VLA-4+ | 87.81 ± 1.512 | 91.72 ± 1.63* | 91.84 ± 0.7279* |
| CD3+CD4+ | 64.35 ± 2.467 | 66.09 ± 2.851 | 61.72 ± 3.732 |
| CD4+HLADR+ | 3.916 ± 0.4157 | 9.216 ± 1.235*** | 16.02 ± 1.423**** |
| CD4+VLA-4 + | 82.84 ± 1.506 | 88.96 ± 2.164** | 87.26 ± 0.8967* |
| VLA4+/CD4+HLADR+ | 73.39 ± 2.862 | 88.78 ± 1.981*** | 88.23 ± 1.528*** |
| CD3+CD8+ | 31.91 ± 2.118 | 28.62 ± 2.256 | 30.08 ± 2.795 |
| CD8+HLADR+ | 13.49 ± 2.55 | 23.02 ± 2.575* | 43.55 ± 3.021**** |
| CD8+VLA-4+ | 95.99 ± 1.537 | 98.13 ± 0.696 | 98.89 ± 0.4381 |
| VLA4+/CD8+HLADR+ | 97.1 ± 1.983 | 99.38 ± 0.1542 | 99.71 ± 0.1322 |
Values are expressed as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.005; ****p < 0.001 versus Control group